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Abstract
Introduction: The regular practice of physical exercise has been associated with beneficial effects on various
pulmonary conditions. We investigated the mechanisms involved in the protective effect of exercise in a model of
lipopolysaccharide (LPS)-induced acute lung injury (ALI).
Methods: Mice were divided into four groups: Control (CTR), Exercise (Exe), LPS, and Exercise + LPS (Exe + LPS).
Exercised mice were trained using low intensity daily exercise for five weeks. LPS and Exe + LPS mice received 200
µg of LPS intratracheally 48 hours after the last physical test. We measured exhaled nitric oxide (eNO); respiratory
mechanics; neutrophil density in lung tissue; protein leakage; bronchoalveolar lavage fluid (BALF) cell counts;
cytokine levels in BALF, plasma and lung tissue; antioxidant activity in lung tissue; and tissue expression of
glucocorticoid receptors (Gre).
Results: LPS instillation resulted in increased eNO, neutrophils in BALF and tissue, pulmonary resistance and
elastance, protein leakage, TNF-alpha in lung tissue, plasma levels of IL-6 and IL-10, and IL-1beta, IL-6 and KC levels
in BALF compared to CTR (P ≤0.02). Aerobic exercise resulted in decreases in eNO levels, neutrophil density and
TNF-alpha expression in lung tissue, pulmonary resistance and elastance, and increased the levels of IL-6, IL-10,
superoxide dismutase (SOD-2) and Gre in lung tissue and IL-1beta in BALF compared to the LPS group (P ≤0.04).
Conclusions: Aerobic exercise plays important roles in protecting the lungs from the inflammatory effects of LPS-
induced ALI. The effects of exercise are mainly mediated by the expression of anti-inflammatory cytokines and
antioxidants, suggesting that exercise can modulate the inflammatory-anti-inflammatory and the oxidative-antioxidative
balance in the early phase of ALI.
Introduction
Acute lung injury (ALI) and its most severe presenta-
tion, acute respiratory distress syndrome (ARDS), are
clinical disorders characterized by hypoxemic respiratory
failure associated with acute pulmonary inflammation
secondary to several different etiologies and exhibit high
mortality rates [1].
The regular practice of exercise has been increasingly
associated with beneficial effects on chronic pulmonary
conditions such as asthma and chronic obstructive
pulmonary disease [2,3]. However, few studies have
investigated the effects of aerobic exercise on acute lung
injury (ALI). In 2008, Mussi et al. demonstrated the ben-
eficial effects of exercise in a rat model of pulmonary
inflammation induced by lung ischemia-reperfusion [4].
Some effects of exercise have been reported also in lipo-
polysaccharide (LPS) models of ALI. Cannon and Kluger
showed in 1984 that mice trained on running wheels and
then injected with Salmonella typhimurium had a signifi-
cantly higher survival rate than sedentary mice [5]. More
recently, Ramos et al. showed that exercise reduced neu-
trophilic inflammation and exhaled NO levels in mice
submitted to intra-nasal instillation of LPS [6]. LPS is
one of the major proinflammatory constituents of the cell
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walls of gram-negative bacteria and has been largely used
in animal models of acute lung inflammation where neu-
trophils, acute phase cytokines and reactive oxygen spe-
cies play major roles [7].
In this study, we investigated the mechanisms involved
in the protective effect of exercise in a model of LPS-
induced ALI. For this purpose, we analyzed lung
mechanics, lung tissue inflammation, protein leakage,
pulmonary and systemic cytokine levels, the expression
of glucocorticoid receptor (Gre) in lung tissue and pul-
monary antioxidant enzyme activity in mice instilled with
LPS after five weeks of daily aerobic exercise.
Materials and methods
This study was approved by the review board for human
and animal studies of the School of Medicine at the Uni-
versity of São Paulo (São Paulo, Brazil), protocol 0402/08.
All animals in the study received humane care in compli-
ance with the Guide for the Care and Use of Laboratory
Animals (NIH publication 85-23, revised 1985).
Animals and experimental design
Thirty-two male BALB/c mice (20g to 25 g) were divided
into four groups (n = 8 in each group): Control (non-
exercised and non-LPS-instilled), Exercise (Exe; exercised
and non-LPS-instilled), LPS (non-exercised and LPS-
instilled), Exe + LPS (exercised and LPS-instilled).
Aerobic exercise treadmill test and exercise conditioning
Animals were initially adapted to the treadmill for three
days (15 minutes, 25% inclination, 0.2 km/hour). After-
wards, a maximal exercise capacity test (test 1) was
performed with a 5-minute warm-up (25% inclination, 0.2
km/hour) followed by an increase in treadmill speed
(0.1 km/hour every 2.5 minutes) until animal exhaustion,
that is, until they were not able to run even after 10
mechanical stimuli. Maximal aerobic capacity (100%) was
established as the maximal speed was reached by each ani-
mal. Mice from the Exe and Exe + LPS groups were then
trained using low intensity exercise (50% of the mean
maximal speed) for 60 minutes/day, 3 days/week, for
5 weeks [3]. The maximal exercise capacity test was
repeated for all animals after five weeks (test 2). The exer-
cise protocol is illustrated in Additional files 1, 2 and 3.
LPS instillation
Forty-eight hours after the last exercise capacity test,
animals from the LPS and Exe + LPS groups received
one intratracheal instillation of 200 µg of Escherichia
coli LPS (L3755, Sigma Aldrich, St. Louis, MO, USA)
suspended in saline solution (total volume = 0.05 ml per
animal). Animals from the Control and Exe groups
received one intratracheal instillation of 0.05 ml saline
solution. For intratracheal instillation, the mice were
anesthetized with ketamine (0.04 ml/mice) and xylasine
(0.1 ml/mice); then, a 1 cm-long midline cervical inci-
sion was made to expose the trachea, and LPS or saline
was instilled using a bent 27-gauge tuberculin needle.
The cervical incision was closed with a 5.0 silk suture,
and the mice were returned to their cages. The animals
recovered rapidly after surgery [8].
Measurement of the exhaled nitric oxide (eNO)
concentration
Twenty-four hours after the intratracheal instillation with
saline or LPS, the animals were anesthetized using pento-
barbital sodium (50 mg/kg i.p.), tracheostomized, and
mechanically ventilated at 60 breaths/min with a tidal
volume of 10 ml/kg using a Harvard 683 ventilator (Har-
vard Apparatus, South Natick, MA, USA). eNO levels
were measured at the expiratory port of the ventilator
using a Mylar bag (3 to 6) for five minutes. The concen-
trations of eNO were measured by chemiluminescence
using a fast-responding analyzer (NOA 280; Sievers
Instruments Inc., Boulder, CO, USA). Before each mea-
surement, the analyzer was calibrated with a certified
47-ppb NO source (White Martins, São Paulo, Brazil)
and a zero NO filter (Sievers Instruments Inc.). To avoid
environmental contamination, an NO filter was attached
to the breathing circuit [9].
Respiratory system mechanics
The tracheal pressure (Ptr) was measured using a pres-
sure transducer (DP 45-28-2114, Validyne, Northridge,
CA, USA) connected to a side tap in the orotrachealcan-
nula. Airflow (V. ) was measured using a pneumotacho-
graph (Fleisch-4.0, OEM Medical, Richmond, VA, USA)
attached to the tracheal cannula and to a differential
pressure transducer (Validyne DP 45-16-2114). Ptr and
V. signs were registered using a Gould RS-3400 recorder
(Gould Instruments, Cleveland, OH, USA), sampled at
200 Hz using an analog-to-digital converter (DT 2801 A,
Data Translation, Marlboro, MA, USA), and stored in a
microcomputer. Lung volume (V) changes were obtained
by electronic integration of V. . The respiratory system
resistance (Rrs) and elastance (Ers) were computed by
least squares fitting of the measured values of Ptr, V, and
V. over 9 to 10 respiratory cycles using the following
equation of motion of the respiratory system:
Ptr (t) = Ers × V(t) + Rrs × V. (t), where t is time. All
data were collected and processed using LABDAT software
(RHT-InfoData, Montreal, Quebec, Canada) [10].
Total and differential cell counts in bronchoalveolar
lavage fluid (BALF)
After the mechanical parameters were measured, the mice
were euthanized by exsanguination (blood collection
through the abdominal vein), and BALF was collected by
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flushing the lungs three times with 0.5 ml of 37°C sterile,
pyrogen-free, physiological saline (0.9% NaCl) via the tra-
cheal cannula. After BALF collection, the samples were
centrifuged at 420 × g at 4°C for 15 minutes, and the
supernatant was stored at -70°C for subsequent analysis of
protein and cytokine levels. The cell pellets were resus-
pended in 1 ml of PBS, and the total cell counts were per-
formed using a Neubauer chamber. For differential cells
counts, cytospin slides were prepared and stained with
Diff-Quick; 300 cells were counted per slide [3,11].
Evaluation of cytokines in BALF
Levels of IL-1b, IL-6, KC (the murine functional homo-
log to IL-8), IL-10 and TNF-a in the cell-free BALF
were evaluated using ELISA in accordance with the
manufacturer’s instructions (Duo Set, R&D Systems,
Minneapolis, MN, US) [12].
Protein leakage in BALF
Proteins from lung lavage supernatant were quantified
using the bicinchoninic acid (BCA) method to evaluate
lung vascular permeability [11].
Evaluation of plasma cytokines
Blood was collected through the abdominal vein for the
measurement of cytokines. The blood was put on ice,
and plasma was collected by centrifugation at 800 × g
for 15 minutes at 4°C, aliquoted and stored at -70°C
until analyzed. Levels of IL-6 and IL-10 were evaluated
using ELISA in accordance with the manufacturer’s
instructions (Duo Set, R&D Systems, Minneapolis, MN,
USA) [12].
Lung morphometry
Lung tissue was fixed in buffered 10% formaldehyde for
24 hours, routinely processed and embedded in paraffin.
Five-µm-thick slides were stained with H & E for analysis
of the polymorphonuclear (PMN) cell content [13]. The
expression of IL-6, IL-10, TNF-a, SOD-2, and glucocorti-
coid receptor was assessed with immunohistochemistry
as previously described [3]. Briefly, sections were deparaf-
finized and 0.3% hydrogen peroxide was applied for
35 minutes to inhibit endogenous peroxidase activity.
Antigen retrieval was performed using citrate solution
for 45 minutes to inhibit endogenous peroxidase activity.
The sections were incubated overnight at 4°C with anti-
IL-6 (1:200) (R&D Systems, Minneapolis, MN, USA),
anti-IL10 (1:900), anti-TNF-a (1:400), anti-SOD-2
(1:400) and anti-Gre (1:500) (Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA). An ABC Vectstain Kit (Vec-
tor Elite PK-6105, Vector Laboratories, CA, USA) was
used as the secondary antibody, and 3,3 diaminobenzi-
dine (Sigma) was used as the chromogen. The sections
were counterstained with Harris hematoxylin (Merck,
Darmstadt, Germany).
Using conventional morphometry, we assessed the
density of PMN cells and cells that were positive for
IL-6, IL-10, TNF-a, SOD-2 and Gre within the alveolar
parenchyma. Using a 100-point grid of known area
(62,500 µm2 at × 400 magnification) attached to the
ocular of the microscope, we counted the number of
points hitting alveolar tissue and the number of PMN
and positive cells in each field. The cell density was
determined as the number of positive cells in each field
divided by the tissue area and expressed as cells/mm2
[13]. The morphometric measurements were performed
on 15 fields for each animal at x400 magnification by an
investigator blinded to the group studied.
Antioxidant enzyme activity assays
The enzymatic activity of catalase (CAT) was deter-
mined in lung homogenates using spectrophotometry.
Catalase activity was evaluated by measuring the con-
sumption of hydrogen peroxide according to Aebi [14].
The decrease in absorbance was monitored spectropho-
tometrically (Biochrom Libra S12) at 25°C and 240 nm
for 60 seconds.
Glutathione peroxidase (GPX) activity was determined
using tert-butylhydroperoxide as substrate, and the for-
mation of oxidized glutathione (GSSG) was indirectly
monitored spectrophotometrically through NADPH
consumption detected for five minutes at 340 nm [15].
Glutathione reductase (GR) activity was determined
based on the method of Carlberg and Mannervik [16].
The reduction of GSSG to GSH was measured through
NADPH consumption, which was monitored spectro-
photometrically at 37°C and 340 nm for five minutes.
Glutathione S-transferase (GST) activity was determined
by measuring the conjugation of 1-chloro-2,4- dinitroben-
zene (CDNB) with reduced glutathione based on the
method of Habig et al. [17]. The formation of the complex
was monitored spectrophotometrically at 25°C and 340
nm for five minutes. The GPX, GR and GST assays were
performed using a Power Wave × 340 spectrophotometer
(Bio-Tek Instruments Inc., software KC4 v3.0).
Malondialdehyde (MDA)
MDA was quantified in homogenates of lung tissue pre-
cipitated with 7.2% trichloroacetic acid solution, centri-
fuged, and incubated with thiobarbituric acid (TBA) at
0.6% (Sigma) for 45 minutes at 90°C [18]. Then, the
supernatant was cooled for five minutes, and n-butanol
was added to extract the color product of the aqueous
solution. After centrifugation, the MDA in the butanol
layer was measured at 532 nm. HPLC analysis was per-
formed using a LC-VP HPLC system from Shimadzu
(Kyoto, Japan). The concentration of total protein in
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each sample of homogenate was determined using the
Bradford Method and BSA as a standard (1 mg/ml).
MDA was expressed in nanomoles per milligram of
total protein.
Statistical analysis
Statistical analysis was performed using the SPSS 15.0®
software package (SPSS, Chicago, Illinois, USA). The
normality of the data was tested using the Kolmogorov-
Smirnov test. Logarithmic data transformation was applied
when the data followed a nonparametric distribution. Pul-
monary resistance was the only parameter that showed a
parametric distribution after logarithmic transformation.
A two-way analysis of variance was performed to resolve
the main effects of LPS and exercise on the parameters
analyzed. This test also produces an interaction term that
identifies whether the effects of one factor (LPS) are influ-
enced by the effects of the other (exercise). The associa-
tions among the various parameters in LPS-instilled
animals were evaluated using Pearson or Spearman tests,
depending on data distribution. The results are expressed
as the mean ± standard deviation or median (interquartile
range). The level of significance was set at P <0.05.
Results
Aerobic exercise treadmill test and exercise conditioning
Non-trained animals showed a significant decrease in
maximal exercise capacity between the first and second
tests (test 1 = 1.5 km/hour, test 2 = 1.3 km/hour,
P = 0.001). Trained animals showed no difference in maxi-
mal exercise capacity between the first and second tests
(test 1 = 1.6 km/hour, test 2 = 1.6 km/hour).
Respiratory mechanics
The graphs in Figure 1 show the pulmonary elastance
and resistance in the four groups. There was a significant
effect of LPS in increasing both pulmonary resistance
and elastance (P = 0.03). We observed an effect of exer-
cise in attenuating the effect of LPS on pulmonary resis-
tance and elastance (P = 0.03).
Concentration of exhaled NO
Figure 2 shows the concentration of eNO in the four
groups. LPS instillation determined an increase in the
concentration of eNO (P <0.001). There was a significant
effect of exercise in attenuating the effect of LPS on eNO
(P = 0.01).
Protein leakage in BALF
We observed an effect of LPS in increasing the protein
concentration in BALF (P <0.001) but exercise did
not attenuate this effect. CTR = 1.88 (0.59) µg/ml,
Exe = 1.73 (0.43) µg/ml, LPS = 3.86 (1.99) µg/ml, and
Exe + LPS = 3.41 (2.47) µg/ml.
Cell counts in BALF
The cell counts in BALF are shown in Table 1. There
was an effect of LPS in increasing the number of total
cells and neutrophils in BALF (P <0.001); exercise did
not attenuate this effect. There was no effect of LPS or
exercise on the number of lymphocytes, macrophages
and eosinophils in BALF.
Plasma and BALF cytokine levels
Plasma and BALF cytokine levels are shown in Table 2.
We observed an effect of LPS in increasing the plasma
level of IL-6 (P <0.001) and IL-10 (P = 0.027), but no
effect of exercise. There was an effect of LPS in increas-
ing the levels of IL-6, IL-1b and KC in BALF (P ≤0.005).
Moreover, the results showed an interaction effect of LPS
and exercise in increasing the IL-1b level in BALF
Figure 1 Values of pulmonary elastance (a) and pulmonary resistance (b). * indicates significant effect of LPS in increasing pulmonary resistance
and elastance (P = 0.03). # indicates significant effect of exercise in attenuating the effect of LPS on pulmonary resistance and elastance (P = 0.03).
Exe (exercise): instilled with saline and trained; LPS: instilled with LPS and untrained; Exe+LPS: instilled with LPS and trained. LPS, lipopolysaccharide.
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(P = 0.04). There was no effect of LPS or exercise on the
levels of TNF-a and IL-10 in BALF.
PMN cell content in lung tissue
Figure 3 shows the PMN cell contents in lung tissue.
LPS instillation resulted in an increase in the PMN cell
content in lung tissue (P <0.001). There was a signifi-
cant effect of exercise in attenuating the effect of LPS
on PMN cell content (P = 0.01).
Cytokine expression in lung tissue
Figure 4 shows the expression of IL-6, IL-10 and TNF-a in
lung tissue. There was no effect of LPS on the expression
of IL-6 in lung tissue, but exercise induced an increase in
IL-6 expression (P <0.001). In addition to a significant
effect of exercise on IL-10 expression in lung tissue
(P = 0.002), we observed a significant interaction effect of
LPS and exercise on the expression of IL-10 (P = 0.013).
LPS instillation resulted in an increase in the expression of
TNF-a in lung tissue (P = 0.001). There was a significant
effect of exercise in attenuating the effect of LPS on TNF-a
expression in lung tissue (P = 0.001).
Antioxidant enzyme activity and MDA levels in lung
tissue
The antioxidant enzyme activity in lung tissue is shown
in Figure 5. LPS instillation determined an increase in
the levels of GPX and GR (P <0.001), but there was no
effect of exercise. There was no effect of LPS or exercise
on the levels of CAT, GST or MDA.
SOD-2 expression in lung tissue
Figure 6 shows the levels of SOD-2 expression in lung
tissue. The results demonstrated a significant effect of
exercise on increasing SOD-2 expression in lung tissue
(P <0.001) and no effect of LPS.
Glucocorticoid receptor expression in lung tissue
Figure 7 shows the expression of Gre in lung tissue in
the four groups. We observed a marginal effect of LPS
(P = 0.05) and a significant effect of exercise (P < 0.001)
Figure 2 Values of exhaled nitric oxide. * indicates significant
effect of LPS in increasing exhaled nitric oxide (P <0.001). #
indicates significant effect of exercise in attenuating the effect of
LPS on exhaled nitric oxide (P = 0.01). CTR (control): instilled with
saline and untrained; Exe (exercise): instilled with saline and trained;
LPS: instilled with LPS and untrained; Exe+LPS: instilled with LPS and
trained. LPS, lipopolysaccharide.
Table 1 Total and differential cell counts in bronchoalveolar lavage fluid (cells/ml).
Control Exercise LPS Exercise+LPS P
total cells 1.35 ± 1.71 1.30 ± 2.01 8.73 ± 3.08a 7.30 ± 0.68 <0.001
neutrophils 0.04 ± 0.04 0.04 ± 0.05 7.28 ± 1.56a 6.00 ± 3.02 <0.001
lymphocytes 0.04 ± 0.07 0.02 ± 0.02 0.15 ± 0.14 0.16 ± 0.20 ns
macrophages 1.11 ± 0.50 1.00 ± 0.60 1.12 ± 0.60 0.86 ± 0.60 ns
eosinophils 0.02 ± 0.04 0 0.01 ± 0.03 0.04 ± 0.05 ns
a indicates the significant effect of LPS in increasing cell counts; values are expressed as the means ± SD. LPS, lipopolysaccharide; ns, non-significant.
Table 2 Cytokine levels in plasma and BALF (ng/ml).
Control Exercise LPS Exercise+LPS P
IL-6 BALF 0.015 ± 0.002 0.011 ± 0.005 0.541 ± 0.445a 0.767 ± 0.664 <0.001
IL-6 plasma 0.016 ± 0.008 0.011 ± 0.003 0.096 ± 0.029a 0.059 ± 0.037 ≤0.001
IL-10 BALF 0.009 ± 0.032 0.050 ± 0.048 0.066 ± 0.072 0.056 ± 0.041 ns
IL-10 plasma 0.013 ± 0.034 0.058 ± 0.278 0.351 ± 0.176a 0.111 ± 0.215 0.027
IL-1b BALF 0.150 ± 0.033 0.106 ± 0.060 0.161 ± 0.186a 0.357 ± 0.246b <0.02
KC BALF 0.017 ± 0.011 0.013 ± 0.007 0.596 ± 0.233a 0.626 ± 0.121 <0.001
TNF-a BALF 0.018 ± 0.016 0.028 ± 0.018 0.027 ± 0.017 0.032 ± 0.029 ns
a indicates the significant effect of LPS in increasing cytokine levels; b indicates the significant interaction effect of LPS and exercise in increasing the cytokine
level; values are means ± SD. BALF, bronchoalveolar lavage fluid; LPS, lipopolysaccharide; ns, non-significant.
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Figure 3 Density of neutrophils in lung tissue. In (a) * indicates significant effect of LPS in increasing the PMN cell content in lung tissue
(P <0.001). # indicates significant effect of exercise in attenuating the effect of LPS on PMN cell content in lung tissue (P = 0.01). CTR (control):
instilled with saline and untrained; Exe (exercise): instilled with saline and trained; LPS: instilled with LPS and untrained; Exe+LPS: instilled with
LPS and trained. The microphotograph illustrates the density of neutrophils in the four groups: b = CTR, c = Exe, d = LPS, e = Exe+LPS. LPS,
lipopolysaccharide; PMN, polymorphonuclear.
Figure 4 Expression of IL-6 (a), IL-10 (b) and TNF-a (c) in lung tissue. In (a) and (b) * indicates a significant effect of exercise in increasing
the expression of IL-6 and IL-10 in lung tissue (P <0.001) and (P = 0.002), respectively. In (c) * indicates significant effect of LPS in increasing the
expression of TNF-a in lung tissue (P = 0.001). # indicates significant effect of exercise in attenuating the effect of LPS on the expression of
TNF-a in lung tissue (P = 0.001). CTR (control): instilled with saline and untrained; Exe (exercise): instilled with saline and trained; LPS: instilled
with LPS and untrained; Exe+LPS: instilled with LPS and trained. LPS, lipopolysaccharide.
Figure 5 GPX (a) and GR (b) enzymes activities in lung tissue. * indicates significant effect of LPS in increasing the levels of GPX and GR
(P <0.001). CTR (control): instilled with saline and untrained; Exe (exercise): instilled with saline and trained; LPS: instilled with LPS and untrained;
Exe+LPS: instilled with LPS and trained. GPX, glutathione peroxidase; GR, glutathione reductase; LPS, lipopolysaccharide.
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in increasing Gre expression. There was no interaction
effect of LPS and exercise.
Correlations
Table 3 lists the correlations among the levels of cyto-
kines, inflammatory cell counts, eNO and mechanical
parameters in animals that received a LPS instillation
(LPS and Exe + LPS groups). We observed significant
correlations among the levels of cytokines within the
three studied compartments (BAL, plasma and lung tis-
sue). There were also significant correlations between the
density of neutrophils and the levels of IL-6 (R = - 0.64,
P = 0.007), IL-10 (R = - 0.55, P = 0.02) and TNF-a
(R = 0.58, P = 0.02) in lung tissue. Further, the levels
of eNO were significantly correlated with values of pul-
monary resistance (R = 0.73, P = 0.001) and elastance
(R = 0.72, P = 0.002).
Discussion
This study investigated the mechanisms involved in the
protective effects of aerobic exercise in a model of ALI
induced by LPS. LPS instillation resulted in increased
levels of eNO, higher numbers of total cells and neutro-
phils in BALF, higher number of neutrophils and TNF-
a positive cells in the lung parenchyma, higher values of
pulmonary resistance and elastance, increased protein
leakage, increases of IL-6 and IL-10 levels in plasma,
increases of IL-1b, IL-6 and KC levels in BALF, and
higher activities of GPX and GR in lung tissue. We
demonstrated that the low intensity exercise performed
during the five weeks before intratracheal instillation of
LPS decreased pulmonary resistance and elastance,
inhibited neutrophilic tissue infiltration and the expres-
sion of TNF-a in lung tissue, decreased the concentra-
tion of eNO, increased the expression of SOD-2,
glucocorticoid receptors, IL-6 and IL-10 in lung tissue
and the levels of IL-1b in BALF. These results suggest
that aerobic exercise may play an important role in pro-
tecting the lung from the inflammatory effects of LPS-
induced ALI by altering the inflammatory profile and
increasing the expression of anti-oxidants in lung tissue.
Few studies to date have investigated the effects of
aerobic preconditioning on the inflammatory changes
involved in acute lung injury. MUSSI et al. evaluated the
benefits of exercise in a rat model of pulmonary inflam-
mation induced by lung ischemia-reperfusion and
observed decreases in protein leakage and plasma levels
of IL-1b and TNF-a and an increase in SOD activity in
trained animals [4]. In the present study, we used intra-
tracheal instillation of LPS as a model of ALI induced by
gram-negative bacteria. The main difference between the
study of MUSSI et al. and ours was the marked effect of
exercise on decreasing LPS-induced pulmonary inflam-
mation as assessed by neutrophilic infiltration and eNO.
We observed an effect of both LPS and exercise on the
release of IL-6. IL-6 is one of the first acute phase cyto-
kines released in sepsis/endotoxemia and is followed by
increases in the levels of IL-1b, IL-8, TNF-a and IL-10 [2].
Consistently, there was an increase in IL-6 levels in both
plasma and BALF of LPS-instilled animals in our model.
Whether the increasing of pulmonary and plasmatic IL-6
in ALI is detrimental or protective is controversial. IL-6
Figure 6 SOD-2 expression in lung tissue. * indicates significant
effect of Exe in increasing the expression of SOD-2 in lung tissue
(P <0.001). CTR (control): instilled with saline and untrained; Exe
(exercise): instilled with saline and trained; LPS: instilled with LPS
and untrained; Exe+LPS: instilled with LPS and trained. LPS,
lipopolysaccharide; SOD-2 superoxide dismutase.
Figure 7 Gre expression in lung tissue. * indicates significant
effect of exercise in increasing the expression of Gre in lung tissue
(P <0.001). # indicates the marginal effect of LPS in this increasing
(P = 0.05). CTR (control): instilled with saline and untrained; Exe
(exercise): instilled with saline and trained; LPS: instilled with LPS
and untrained; Exe+LPS: instilled with LPS and trained. Gre,
glucocorticoid receptor; LPS, lipopolysaccharide.
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was previously considered exclusively as a pro-inflamma-
tory cytokine, and the circulating levels of IL-6 were
directly correlated with the severity of ALI [19]. Currently,
the anti-inflammatory effects of IL-6 have been demon-
strated [20-24]. Evidence for the protective anti-inflamma-
tory effects of IL-6 is derived from studies that show that
endogenous IL-6 in endotoxin-induced ALI controls the
level of pro-inflammatory cytokines and neutrophilic
inflammation [24]; also, the administration of IL-6 induces
SOD production and reduces LPS-induced neutrophilic
infiltration in liver in a model of endotoxemia in rats [21].
Further, it has been reported that IL-6 plays a protective
role in limiting the disruption of the alveolar barrier by
neutrophils [23].
An exercise-induced increase in IL-6 expression in
lung tissue was observed in our trained animals of both
the Exe and LPS + Exe groups. Evidence regarding the
effects of exercise on the release of IL-6 is accumulating
[2,25,26]. An increase in circulating levels of IL-6 is con-
sistently found during aerobic exercise; however, a
decline in the levels of IL-6 has been observed during
the post-exercise period [2,25]. The dynamics of the
plasma variation of IL-6 levels induced by exercise could
explain the low levels of plasmatic IL-6 observed in our
Exe group because this analysis was performed 72 hours
after the last training session.
IL-6 has been shown to stimulate the production of
IL-10, a cytokine with well known anti-inflammatory
effects [2,21,27,28]. Interestingly, in our animals the higher
tissue expression of IL-6 was associated with the higher
expression of IL-10 in lung tissue; we further observed a
negative association between these two anti-inflammatory
cytokines and the density of neutrophils in lung tissue.
Distinct mechanisms have been proposed for the anti-
inflammatory effects of IL-6 in acute or chronic conditions
[24]. In acute inflammatory responses, as those elicited by
LPS, IL-6 operates to control the extent of tissue inflam-
matory responses by inhibition of pro-inflammatory cyto-
kines and induction of anti-inflammatory molecules.
When chronically released, as when induced by repeated
bouts of exercise, IL-6 could induce the beneficial anti-
inflammatory effects by modulation of the immune sys-
tem, as suggested in previous studies that showed that
IL-6 treatment may modulate the hypothalamic-pituitary-
adrenal (HPA) axis and autoregulate serum IL-6 levels in
response to LPS [21,26,29]. Furthermore, prolonged
administration of IL-6 in humans led to adrenal enlarge-
ment and identification of IL-6 receptors in the adrenal
cortex in mice led to the suggestion that the direct stimu-
latory effects of IL-6 mediate glucocorticoid release [29].
Increased glucocorticoid secretion leads to the restraining
of the further production of pro-inflammatory mediators
[29,30], thus preventing propagation of the stress response
[29]. We believe that exercise could have induced the
release of small doses of IL-6 after each training period in
our animals, and this would chronically modulate the
HPA axis to stimulate the constant release of glucocorti-
coids [26,29]. Although we did not measure the serum
levels of glucocorticoids, the increase in the expression of
glucocorticoid receptors in pulmonary inflammatory cells
in the trained animals suggests that modulation of the
HPA axis could be one of the anti-inflammatory effects
Table 3 Significant correlations between cytokine levels, inflammatory cell counts, exhaled NO, and mechanical
parameters in the LPS and exercise + LPS groups.
Neutro T Neutro B IL-10 T IL-10 B IL-6 T IL-6 B IL-1b B Exhaled NO
Neutro T R = -0.553
P = 0.026
IL-10 P R = 0.678
P = 0.015
IL-6 T R = -0.640
P = 0.007
R = -0.574
P = 0.020
R = 0.524
P = 0.037
IL-6 B R = 0.869
P < 0.001
IL-6 P R = 0.636
P = 0.026
KC B R = 0.504
P = 0.047
R = 0.729
P = 0.001
R = 0.653
P < 0.006
TNF-a T R = 0.578
P = 0.019
R = -0.685
P = 0.003
R = -0.597
P = 0.015
Elastance R = 0.718
P = 0.002
Resistance R = 0.729
P = 0.001
BALF, bronchoalveolar lavage fluid; IL-1b B, IL-1b in BALF; IL-6 B, IL-6 in BALF; IL-6 S, IL-6 in plasma; IL-6 T, IL-6 in lung tissue; IL-10 B, IL-10 in BALF; IL-10 S, IL-10
in plasma; IL-10 T, IL-10 in lung tissue; KC B, KC in BALF; LPS, lipopolysaccharide; Neutro B, neutrophil in BALF; Neutro T, neutrophil in lung tissue; TNF-a T, TNF-a
in lung tissue.
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induced by exercise in our model. Taken together, our
findings suggest that pulmonary release of IL-6 and IL-10
is a major mechanism involved in the protective effect of
exercise in this LPS-induced ALI model.
We observed an interaction effect of LPS and exercise
in increasing the levels of IL-1b in BALF, indicating that
exercise exacerbates the effect of LPS in increasing
IL-1b levels. IL-1b is involved in the repair of the alveo-
lar epithelium in the early phase of ARDS through acti-
vation of the epithelial epidermal growth factor/
transforming growth factor a pathway [31-33]. One of
the most important factors that determine the severity
of lung injury in ARDS is the magnitude of injury to the
alveolar epithelial barrier. The possibility of decreasing
the inflammatory process at an early stage or accelerat-
ing tissue repair can be a major determinant of recovery
[31]. Although the process of alveolar epithelial repair
involves several growth factors, cytokines and various
extracellular matrix components, it is possible that a
further protective effect of exercise on ALI is to pro-
mote early tissue repair through IL1-b release.
Levels of TNF-a were not elevated in BALF after LPS
instillation but increased expression of TNF-a in lung
tissue was observed in LPS-treated animals. Aerobic
exercise resulted in a significant effect on decreasing
LPS-induced TNF-a expression. Moreover, values of
TNF-a in lung tissue were correlated with the density of
neutrophils. TNF-a is a major mediator of sepsis and
endotoxin-induced ALI; after endotoxin infusion in ani-
mals, the level of TNF-a peaks in one to two hours in
the serum and in eight hours in BALF. However, due to
its short half-life, TNF-a is rapidly cleared and returns to
baseline levels within a few hours [34,35]. We believe
that this dynamic of the release and clearance of TNF-a
could explain the observed low levels of this cytokine in
the BALF of our animals, which was collected 24 hours
after LPS instillation. We also observed a striking
decrease of eNO in our exercised animals. Elevated NO
levels are thought to play a central role in tissue damage
observed during septic shock [21]. Previous results sug-
gest that NO release after LPS challenge is mediated
through IFN-g and TNF-a [36]. Based on previous obser-
vations that pretreatment with IL-6 decreased the levels
of TNF-a, NO and other pro-inflammatory cytokines in
a model of endotoxemia in mice [21], we suggest that in
our model, the low levels of eNO and TNF-a in the exer-
cised animals could, at least in part, be secondary to the
continuous release of IL-6 induced by exercise. The nega-
tive correlation between the levels of TNF-a and IL-6 in
lung tissue in our animals is compatible with this
hypothesis.
The aerobic exercise did not alter the effects of LPS
on KC release and protein leakage in BALF. These find-
ings were unexpected because KC is a major neutrophil
chemotactic factor, and exercise induced a significant
reduction in neutrophil density. KC levels were not
measured in plasma or pulmonary tissue, limiting the
interpretation of our results.
We observed an effect of exercise on decreasing pul-
monary resistance and elastance in LPS-instilled animals.
Alteration of resistive forces and tissue viscoelastic prop-
erties is a major characteristic of ALI and is associated
with alveolar barrier disruption, alveolar edema, surfac-
tant dysfunction, collapse and alveolar inflammation [8].
In our animals, there was no significant effect of exercise
on protein leakage, and the decrease of pulmonary resis-
tance and elastance in LPS-instilled exercised mice is
likely related to the decrease in pulmonary inflammation.
The significant correlation between the levels of eNO
and values of resistance and elastance is consistent with
this mechanism.
To investigate the role of oxidative stress, we analyzed
the enzymatic activities of GST, CAT, GPX, and GR,
the levels of MDA and the expression of SOD-2 in lung
tissue. The levels of MDA, which were used as an index
of oxidative stress, were not different between the LPS
group and controls. Previous studies have shown that
the levels of MDA peak four to five hours after LPS
instillation [37,38]. Changes in MDA levels can be unde-
tectable after 8 or 24 hours [38], as observed in our ani-
mals. Moreover, we observed that LPS instillation
induced activation of the antioxidant glutathione path-
way by increasing the activities of GPX and GR, indicat-
ing a possible physiologic response to an oxidative stress
[39]. Exercise determined an increase in the expression
of SOD-2 in lung tissue. SOD-2 is exclusively localized
to the mitochondria, a critical cell organelle both in cel-
lular energy metabolism and cell survival [40]. Overall,
SOD-2 is most highly expressed in alveolar type II
epithelial cells and alveolar macrophages, cell types with
relatively high metabolic capacity, and plays a major role
in protecting lung tissue against free radicals [40].
Conclusions
In conclusion, our results show that aerobic exercise
plays an important role in protecting the lung from the
inflammatory effects of LPS-induced ALI. The effects of
exercise are mainly mediated by the increased expres-
sion of anti-inflammatory cytokines and antioxidants,
suggesting that aerobic exercise can modulate the
inflammatory-anti-inflammatory and the oxidative-anti-
oxidative balance in the early phase of ARDS.
Key Messages
• Aerobic exercise performed during five weeks prior
to LPS instillation attenuates the pulmonary changes
induced by LPS.
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• The beneficial effects of exercise in this ALI model
are mainly mediated by the anti-inflammatory cyto-
kines IL-6 and IL-10 and by the expression of SOD-2.
• Our data suggest that exercise can modulate the
inflammatory-anti-inflammatory and the oxidative-
antioxidative balance in the early phase of ALI.
Additional material
Additional file 1: Treadmill for mice exercise. The picture illustrates
the treadmill used for mice exercise.
Additional file 2: Treadmill for mice exercise. The picture illustrates
the mice during exercise.
Additional file 3: Video of treadmill with mice. The video illustrates
the mice during exercise.
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